Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Motor Evoked Potential Monitoring: An Imperative during Open Thoraco-Abdominal Aortic Aneurysm Repair.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026

Same author

Amputation-Free Survival, WIfI Stage, and GLASS Classifications in Distal Crural or Pedal Bypass for Chronic Limb-Threatening Ischemia.

Journal of clinical medicine·2024

Same author

Comparable bleeding and inflammation outcomes between heparin-coated and uncoated minimal invasive extracorporeal circuits in isolated coronary artery bypass surgery - A double-blinded randomized control trial.

Perfusion·2024

Same author

Increase in Oral Streptococcal Endocarditis Among Moderate-Risk Patients: Impact of Guideline Changes on Endocarditis Prevention.

JACC. Advances·2024

Same author

Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial.

Perfusion·2024

Same author

Conventional versus minimally invasive extra-corporeal circulation in patients undergoing cardiac surgery: A randomized controlled trial (COMICS).

Perfusion·2024

Same journal

Comment: Topical Use of Tranexamic Acid in Cardiac Surgery: A Meta-Analysis.

The Thoracic and cardiovascular surgeon·2026

Same journal

Long-Term Outcomes after Redo Coronary Artery Bypass Grafting: A Propensity-Matched Analysis of On-Pump and Off-Pump Techniques.

The Thoracic and cardiovascular surgeon·2026

Same journal

PULMONARY ENDARTERECTOMY IN PEDIATRIC PATIENTS: INSTITUTIONAL EXPERIENCE.

The Thoracic and cardiovascular surgeon·2026

Same journal

Surgical Repair of Acquired Ventricular Septal Defects: Outcomes and Quality of Life.

The Thoracic and cardiovascular surgeon·2026

Same journal

The Use of Intra-Aortic Balloon Pumping in Cardiac Surgery.

The Thoracic and cardiovascular surgeon·2026

Same journal

Conflicts of Interest-From "Jein" to Transparency.

The Thoracic and cardiovascular surgeon·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Standardization of Myocardial Protection: Comment on Cardiac Surgery 2023 Reviewed.

Thierry Carrel^1,2, Jürg Schmidli^2,3

¹Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.

The Thoracic and Cardiovascular Surgeon

|December 9, 2024

Summary

This summary is machine-generated.

A new cardioplegia solution, Cardioplexol™, simplifies administration and ensures immediate cardiac arrest for myocardial protection. This innovation offers a standardized approach to heart muscle protection during surgery, proving non-inferior to existing methods.

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

Related Experiment Videos

Last Updated: Jun 5, 2025

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

Area of Science:

Cardiovascular Surgery
Cardiac Anesthesia
Cardiomyocyte Protection

Background:

Cardioplegia, crucial for myocardial protection during cardiac surgery, lacks standardization despite its 50-year history.
Diverse cardioplegic solutions and administration methods (cold/warm, crystalloid/blood, antegrade/retrograde) exist, leading to variability.
Recent CE marking approval of Cardioplexol™ introduces a novel, standardized cardioplegia solution.

Discussion:

Cardioplexol™ offers a simplified administration protocol, reducing manipulation errors and enabling immediate diastolic arrest.
Its low crystalloid volume (100mL induction, 100mL repeat) minimizes hemodilution, negating the need for intraoperative filtration.
Aortic root cannula injection eliminates the requirement for an additional cardioplegia pump and disposable tubing.

Key Insights:

Cardioplexol™ provides immediate diastolic arrest for efficient cardiac surgery initiation.
The solution's low volume and simplified delivery system enhance surgical workflow and safety.
Clinical trials demonstrate Cardioplexol™ is non-inferior to the Buckberg solution for myocardial protection.

Outlook:

Cardioplexol™ has the potential to standardize myocardial protection protocols in cardiac surgery.
Further adoption may streamline surgical procedures and improve patient outcomes.
This innovation represents a significant advancement in cardioplegia delivery and efficacy.